No to gene patents, says Euro group

Patents should be granted only for genetic tests, not for genes and DNA sequences, a working party from the linkurl:European Society of Human Genetics;http://www.eshg.org/ (ESHG) and linkurl:EuroGentest,;http://www.eurogentest.org/ a European Union-funded initiative to improve linkurl:genetic testing;http://www.the-scientist.com/article/display/14181/ in Europe, said at a press conference on Thursday (April 24) according to linkurl:Medical News Today.;http://www.medicalnewstoday.com/articles/105478.php The recommendations are the result of a four-year investigation and a series of workshops involving the ESHG's linkurl:Public and Professional Policy Committee;http://www.eshg.org/PPPC.htm (PPPC) and the linkurl:Patenting and Licensing Committee;http://www.eshg.org/plc.htm (PLC), in consultation with a large number of scientists, ethicists, lawyers, and technology transfer specialists. "Nowadays, identifying new genes is very obvious, and all the methods are well-established, so it should not be patentable anymore," Ségolène Aymé, a medical geneticist at the French National Institute for Health and Medical Research in Paris and head of the PPPC, told The Scientist. "What is patentable is the inventive process — if you can describe how to use a gene for a specific purpose — but not the gene itself." The ESHG group is calling for new models for licensing within existing linkurl:patent;http://www.the-scientist.com/news/display/53497/ legislation, rather than a complete overhaul of the genetic intellectual property protection system. Their recommendations will now be taken to the European Patent Commission and the European Parliament. Aymé said the European Patent Commission hurt the research environment by granting a number of patents for genetic claims that were too broad. "Most of the problems come from patents granted for bad reasons," she said. The PPPC is urging better training for genetic patent reviewers and the use of a scientific advisory committee to evaluate the scope of patent claims. "The main debate now is not if genes should be patented or not, but rather are we stopping inventions because too many patents are preventing researchers from getting licenses," said Aymé. The PPPC's recommendations are linkurl:published;http://www.nature.com/ejhg/journal/v16/n1s/abs/5201929a.html in the May issue of the European Journal of Human Genetics.

No to gene patents, says Euro group

The Scientist ARCHIVES

Become a Member of

Meet the Author

Elie Dolgin

Related Research Resources

Study Confirms Safety of Genetically Modified T Cells

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

TaqMan Probe & Assays: Unveil What's Possible Together

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Making Real-Time PCR More Straightforward

Products

Product News

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours